P-1382. Stress hyperglycemia during tuberculosis treatment and rate of sputum culture conversion

Read full text
Authors: Fay Willis, Maia Kipiani, Dzigbordi Kamasa-Quashie, Tekla Madzgharashvili, Inga Davitadze, Victoria C Ontiveros, Hardy Kornfeld, Lorissa J. Smulan, Francisco J. Pasquel, Russell Ryan Kempker, Jeffrey M. Collins, A Nichole Evans
+3 more Angie Campbell, Neel Gandhi, Matthew James Magee
Cited by: 0

Abstract

Abstract Background Tuberculosis (TB) is the leading cause of infectious disease mortality worldwide. Diabetes increases the risk of poor TB treatment outcomes and is increasingly prevalent in high-TB burden settings. However, whether TB-induced stress hyperglycemia impacts TB treatment outcomes is unclear. We compared TB culture conversion rates among stress hyperglycemic participants to those with diabetes/pre-diabetes or euglycemia. Methods This is an on-going prospective cohort study of adults with newly-diagnosed pulmonary TB disease in the country of Georgia. At treatment initiation, participants were categorized as having diabetes (DM)/prediabetes (pre-DM), euglycemia, or stress hyperglycemia (defined as hemoglobin A1c [HbA1c] ≥ 5.7% or fasting blood glucose [FBG] ≥ 100 mg/dl at TB treatment start and HbA1c < 5.7% or FBG < 100 mg/dl within 2 months). Culture conversion was defined as two consecutive monthly negative Mtb cultures with no subsequent positive cultures. Culture conversion rates were compared by glycemic status using Kaplan Meier curves and hazards regression. Results Among 225 participants (64% of target enrollment) with culture data available to date: median age was 40 years (IQR 29-54), median BMI was 20.7 kg/m2 (IQR 18.6-23.8), and 38% were female. At enrollment, 43% had stress hyperglycemia, 17% had DM or pre-DM, and 40% had euglycemia. Overall, 200 participants (89%) achieved culture conversion by 2 months, with the lowest proportion of culture conversion in the stress hyperglycemia group (82% converted, vs 89% DM/pre-DM and 96% euglycemic; p=0.01). Median time to culture conversion was 58 days (IQR 30-62) among participants with stress hyperglycemia, compared to 59 days (IQR 31-72) among DM/pre-DM and 51 days (IQR 30-62) among euglycemic participants (Figure 1; p=0.10). After adjusting for age, sex, and baseline BMI, participants with stress hyperglycemia (HR 0.75, 95%CI 0.5-1.0) and DM/pre-DM (HR 0.72, 95%CI 0.5-1.1) had reduced culture conversion rates compared to euglycemic participants. Conclusion In preliminary analysis, we found >40% of participants had stress hyperglycemia at TB treatment initiation. Participants with stress hyperglycemia trended to have reduced culture conversion rates compared to those with euglycemia. Disclosures Francisco J. Pasquel, MD, MPH, Dexcom: Grant/Research Support|Dexcom: Grant/Research Support|Dexcom: Honoraria|Ideal Medical Technologies: Grant/Research Support|Insulet: Grant/Research Support|Novo Nordisk: Grant/Research Support|Tandem Diabetes Care: Grant/Research Support

Fields of Study & Subjects

Tuberculosis Research and Epidemiology Hyperglycemia and glycemic control in critically ill and hospitalized patients Diabetes Management and Research

Publication details

Journal / source
Open Forum Infectious Diseases
Volume
13
Issue
Supplement_1
Publication date
1 January 2026
Language
EN